{"messages":[{"status":"ok","category":"all","interval":"2020-03-21:2020-03-24","funder":"all","cursor":"45","count":30,"count_new_papers":"106","total":"106"}], "collection":[{"title":"Assessing the potential impacts of COVID-19 in Brasil: Mobility, Morbidity and Impact to the Health System","authors":"Coelho, F. C.; Lana, R. M.; Cruz, O. G.; Codeco, C. T.; Villela, D.; Bastos, L. S.; Piontti, A. P. y.; Davis, J. T.; Vespignani, A.; Gomes, M. F. C.","author_corresponding":"Marcelo F.C. Gomes","author_corresponding_institution":"Fiocruz, Scientific Computing Program, Rio de Janeiro, Brazil","doi":"10.1101\/2020.03.19.20039131","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039131.source.xml","abstract":"BackgroundBrazil detected community transmission of COVID-19 on March 13, 2020. In this study we identify which areas in the country are most vulnerable for COVID-19, both in terms of the risk of arrival of COVID-19 cases and the risk of sustained transmission. The micro-regions with higher social vulnerability are also identified.\n\nMethodsProbabilistic models were used to calculate the probability of COVID-19 spread from Sao Paulo and Rio de Janeiro, according to previous data available on human mobility in Brazil. We also perform a multivariate cluster analysis of socio-economic indices to identify areas with similar social vulnerability.\n\nResultsThe results consist of a series of maps of effective distance, outbreak probability, hospital capacity and social vulnerability. They show areas in the North and Northeast with high risk of COVID-19 outbreak that are also highly vulnerable.\n\nInterpretationThe maps produced are useful for authorities in their efforts to prioritize actions such as resource allocation to mitigate the effects of the pandemic and may help other countries to use a similar approach to predict the virus route in their countries as well.\n\nFundingNo funding","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Role of meteorological temperature and relative humidity in the January-February 2020 propagation of 2019-nCoV in Wuhan, China","authors":"Alvarez-Ramirez, J.; MERAZ, M.","author_corresponding":"Jose Alvarez-Ramirez Sr.","author_corresponding_institution":"Universidad Autonoma Metropolitana-Iztapalapa","doi":"10.1101\/2020.03.19.20039164","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039164.source.xml","abstract":"Identified in December 2019, the 2019-nCoV emerged in Wuhan, China, and its spread increased rapidly, with cases arising across Mainland China and several other countries. By January 2020, the potential risks imposed by 2019-nCoV in human health and economical activity were promptly highlighted. Considerable efforts have been devoted for understanding the transmission mechanisms aimed to pursue public policies oriented to mitigate the number of infected and deaths. An important question requiring some attention is the role of meteorological variables (e.g., temperature and humidity) in the 2019-nCoV transmission. Correlations between meteorological temperature and relative humidity with the number of daily confirmed cases were explored in this work for the epicenter city of Wuhan, China for the period from 29 January to March 6, 2020. Long-term trend of temperature and relative humidity was obtained with a 14-days adjacent-averaging filter, and lagged correlations of the number of daily confirmed cases were explored. The analysis showed negative correlations between temperatures with the number of daily confirmed cases. Maximum correlations were found for 6-day lagged temperatures, which is likely reflecting the incubation period of the virus. It was postulated that the indoor crowding effect is responsible of the high incidence of 2019-nCoV cases, where low absolute humidity and close human contact facilitate the transport of aerosol droplets.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Modelling the epidemiological trend and behavior of COVID-19 in Italy","authors":"Rovetta, A.; Bhagavathula, A. S.","author_corresponding":"Alessandro Rovetta","author_corresponding_institution":"Mensana srls","doi":"10.1101\/2020.03.19.20038968","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038968.source.xml","abstract":"As of May 14, 2020, Italy has been one of the red hotspots for the COVID-19 pandemic. With over 220,000 confirmed cases and almost 33,000 confirmed deaths reported from February, it is necessary to fully understand the spread of COVID-19 in this country. By S.E.I.R. simulation, we estimated the most representative basic reproduction number R0 for the three most affected regions from February 22 to March 14, 2020. In doing so, we have been able to evaluate the consistency of the first containment measures until the end of April, as well as identify possible SARS-CoV-2 local behavior mutations and specificities. Next to that, through new estimates of the infection mortality rate, we recalculated a more plausible number of real infected. Finally, given the absolutely anomalous trend of the Lombardy region, we looked for correlations between COVID-19 total cases and air pollutants such as PM 10 and PM 2.5.","funder":"NA","published":"10.7759\/cureus.9884","server":"medRxiv"},{"title":"Trend analysis of the COVID-19 pandemic in China and the rest of the world","authors":"Weber, A.; Iannelli, F.; Goncalves, S.","author_corresponding":"Sebastian Goncalves","author_corresponding_institution":"Instituto de Fisica, Universidade Federal do Rio Grande do Sul, Porto Alegre, RS, Brazil","doi":"10.1101\/2020.03.19.20037192","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20037192.source.xml","abstract":"The recent epidemic of Coronavirus (COVID-19) that started in China has already been \"exported\" to more than 140 countries in all the continents, evolving in most of them by local spreading. In this contribution we analyze the trends of the cases reported in all the Chinese provinces, as well as in some countries that, until March 15th, 2020, have more than 500 cases reported. Notably and differently from other epidemics, the provinces did not show an exponential phase. The data available at the Johns Hopkins University site [1] seem to fit well an algebraic sub-exponential growing behavior as was pointed out recently [2]. All the provinces show a clear and consistent pattern of slowing down with growing exponent going nearly zero, so it can be said that the epidemic was contained in China. On the other side, the more recent spread in countries like, Italy, Iran, and Spain show a clear exponential growth, as well as other European countries. Even more recently, US --which was one of the first countries to have an individual infected outside China (Jan 21st, 2020)-- seems to follow the same path. We calculate the exponential growth of the most affected countries, showing the evolution along time after the first local case. We identify clearly different patterns in the analyzed data and we give interpretations and possible explanations for them. The analysis and conclusions of our study can help countries that, after importing some cases, are not yet in the local spreading phase, or have just started.\n\nHIGHLIGHTSO_LIAll the provinces of China show very similar epidemic behaviour.\nC_LIO_LIEarly stages of spreading can be explained in terms of SIR standard model, considering that reported cases accounts for the removed individuals, with algebraic growing (sub-exponential) in most locations.\nC_LIO_LIWorldwide, we observe two classes of epidemic growth: sub-exponential during almost all stages (China and Japan) and exponential on the rest of the countries, following the early stage.\nC_LIO_LIThe exponential growth rates ranges from 0.016day-1 (South Korea) to 0.725day-1 (Brunei) which means 1.6% to 107% of new cases per day, for the different countries but China.\nC_LI","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Covid-19 health care demand and mortality in Sweden in response to non-pharmaceutical (NPIs) mitigation and suppression scenarios","authors":"Rocklov, J.","author_corresponding":"Joacim Rocklov","author_corresponding_institution":"Umea University","doi":"10.1101\/2020.03.20.20039594","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039594.source.xml","abstract":"BackgroundWhile the COVID-19 outbreak in China now appears surpressed, Europe and the US have become the epicenters, both reporting many more deaths than China. Responding to the pandemic, Sweden has taken a different approach aiming to mitigate, not suppressing community transmission, by using physical distancing without lock-downs. Here we contrast consequences of different responses to COVID-19 within Sweden, the resulting demand for care, intensive care, the death tolls, and the associated direct healthcare related costs.\n\nMethodsWe use an age stratified health-care demand extended SEIR compartmental model calibrated to the municipality level for all municipalities in Sweden, and a radiation model describing inter-municipality mobility.\n\nResultsOur model fit well with the observed deaths in Sweden up to 20th of April, 2020. The intensive care unit (ICU) demand is estimated to reach almost 10,000 patients per day by early May in an unmitigated scenario, far above the pre-pandemic ICU capacity of 526 beds. In contrast, a scenario with moderate physical distancing and shielding of elderly in combination with more effective isolation of infectious individuals would reduce numbers to below 500 per day. This would substantially flatten the curve, extend the epidemic period, but a risk resurgence is expected if measures are relaxed. The different scenarios show quite different death tolls up to the 1th of September, ranging from 5,000 to 41,000 deaths, exluding deaths potentially caused by ICU shortage. Further, analyses of the total all-cause mortality in Stockholm indicate that a confirmed COVID-19 death is associated with a additional 0.40 (95% Cl: 0.24, 0.57) all-cause death.\n\nConclusionThe results of this study highlight the impact of different combinations of non-pharmaceutical interventions, especially moderate physical distancing and shielding of elderly in combination with more effective isolation of infectious individuals, on reducing deaths and lower healthcare costs. In less effective mitigation scenarios, the demand on ICU beds would rapidly exceed capacity, showing the tight interconnection between the healthcare demand and physical distancing in the society. These findings have relevance for Swedish policy and response to the COVID-19 pandemic and illustrate the importance of maintaining the level of physical distancing for a longer period to suppress or mitigate the impacts from the pandemic.\n\nKey messagesO_LIWe find physical distancing and isolation of infectious individuals without lockdown is effective in mitigating much of the negative direct health impact from the COVID-19 pandemic in Sweden, but has a higher death toll compared to other Scandinavian countries who did implement a lockdown\nC_LIO_LIBetween the start of the Swedish model of physical distancing and shiedling the elderly in March to late April, it appears Sweden has managed to ensure that ICU demands do not exceed ICU capacities and that deaths are substantially reduced compared to a counterfactual scenario.\nC_LIO_LIIn the counterfactual scenario (eg no public health interventions), the intensive care unit demand is estimated to be almost 20 times higher than the intensive care capacity in Sweden and the number of deaths would be between 40,000 to 60,000\nC_LIO_LIUnder current mitigation strategies, the death toll, health care need, and its associated cost are, however, still substantial, and it is likely to continue to rise unless the virus is suppressed, or eliminated. In the stronger mitigation and suppression scenarios, including the scenario fitting best to data from Sweden by late April 2020, there is an obvious risk of resurgence of the epidemic unless physical distancing, shielding of the elderly, and home isolation are effectively sustained.\nC_LIO_LIAdditional analyses indicate all-cause non COVID-19 excess mortality rises with 0.4 deaths per every reported COVID-19 death in the Stockholm area.\nC_LI","funder":"NA","published":"10.1093\/ije\/dyaa121","server":"medRxiv"},{"title":"Geo temporal distribution of 1,688 Chinese healthcare workers infected with COVID-19 in severe conditions, a secondary data analysis","authors":"Gao, W.; Sanna, M.; Wen, C. P.","author_corresponding":"Wayne Gao","author_corresponding_institution":"Taipei Medical University","doi":"10.1101\/2020.03.19.20032532","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20032532.source.xml","abstract":"IntroductionThe COVID-19 outbreak is posing an unprecedented challenge to healthcare workers. This study analyzes the geo-temporal effects on disease severity for the 1,688 Chinese healthcare workers infected with COVID-19.\n\nMethodUsing the descriptive results recently reported by the Chinese CDC, we compare the percentage of infected healthcare workers in severe conditions over time and across three areas in China, and the fatality rate of infected healthcare workers with all the infected individuals in China aged 22-59 years.\n\nResultsAmong the infected Chinese healthcare workers whose symptoms onset appeared during the same ten-day period, the percentage of those in severe conditions decreased statistical significantly from 19.7% (Jan 11 - 20) to 14.4% (Jan 21 - 31) to 8.7% (Feb 1 - 11). Across the country, there was also a significant difference in the disease severity among patients symptoms onset during the same period, with Wuhan being the most severe (17%), followed by Hubei Province (10.4%), and the rest of China (7.0%). The case fatality rate for the 1,688 infected Chinese healthcare workers was significantly lower than that for the 29,798 infected patients aged 20-59 years--0.3% (5\/1,688) vs. 0.65% (193\/29,798), respectively.\n\nConclusionThe disease severity improved considerably over a short period of time in China. The more severe conditions in Wuhan compared to the rest of the country may be attributable to the draconian lockdown. The clinical outcomes of infected Chinese healthcare workers may represent a more accurate estimation of the severity of COVID-19 for those who have access to quality healthcare.","funder":"NA","published":"10.1371\/journal.pone.0233255","server":"medRxiv"},{"title":"Healthcare worker absenteeism, child care costs, and COVID-19 school closures: a simulation analysis","authors":"Chin, E. T.; Huynh, B. Q.; Lo, N. C.; Hastie, T.; Basu, S.","author_corresponding":"Benjamin Q Huynh","author_corresponding_institution":"Stanford University","doi":"10.1101\/2020.03.19.20039404","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039404.source.xml","abstract":"BackgroundSchool closures have been enacted as a measure of mitigation during the ongoing COVID-19 pandemic. It has been shown that school closures could cause absenteeism amongst healthcare workers with dependent children, but there remains a need for spatially granular analyses of the relationship between school closures and healthcare worker absenteeism to inform local community preparedness.\n\nMethodsWe provide national- and county-level simulations of school closures and unmet child care needs across the United States. We develop individual simulations using county-level demographic and occupational data, and model school closure effectiveness with age-structured compartmental models. We perform multivariate quasi-Poisson ecological regressions to find associations between unmet child care needs and COVID-19 vulnerability factors.\n\nResultsAt the national level, we estimate the projected rate of unmet child care needs for healthcare worker households to range from 7.5% to 8.6%, and the effectiveness of school closures to range from 3.2% (R0 = 4) to 7.2% (R0 = 2) reduction in fewer ICU beds at peak demand. At the county-level, we find substantial variations of projected unmet child care needs and school closure effects, ranging from 1.9% to 18.3% of healthcare worker households and 5.7% to 8.8% reduction in fewer ICU beds at peak demand (R0 = 2). We find significant positive associations between estimated levels of unmet child care needs and diabetes prevalence, county rurality, and race (p < 0.05). We estimate costs of absenteeism and child care and observe from our models that an estimated 71.1% to 98.8% of counties would find it less expensive to provide child care to all healthcare workers with children than to bear the costs of healthcare worker absenteeism during school closures.\n\nConclusionsSchool closures are projected to reduce peak ICU bed demand, but could disrupt healthcare systems through absenteeism, especially in counties that are already particularly vulnerable to COVID-19. Child care subsidies could help circumvent the ostensible tradeoff between school closures and healthcare worker absenteeism.","funder":"NA","published":"10.1186\/s12916-020-01692-w","server":"medRxiv"},{"title":"The Population Attributable Fraction (PAF) of cases due to gatherings and groups with relevance to COVID-19 mitigation strategies","authors":"Brooks-Pollock, E.; Read, J. M.; House, T.; Medley, G.; Keeling, M. J.; Danon, L.","author_corresponding":"Ellen Brooks-Pollock","author_corresponding_institution":"University of Bristol","doi":"10.1101\/2020.03.20.20039537","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039537.source.xml","abstract":"BackgroundMany countries have banned groups and gatherings as part of their response to the pandemic caused by the coronavirus, SARS-CoV-2. Although there are outbreak reports involving mass gatherings, the contribution to overall transmission is unknown.\n\nMethodsWe used data from a survey of social contact behaviour that specifically asked about contact with groups to estimate the Population Attributable Fraction (PAF) due to groups as the relative change in the Basic Reproduction Number when groups are prevented.\n\nFindingsGroups of 50+ individuals accounted for 0.5% of reported contact events, and we estimate that the PAF due to groups of 50+ people is 5.4% (95%CI 1.4%, 11.5%). The PAF due to groups of 20+ people is 18.9% (12.7%, 25.7%) and the PAF due to groups of 10+ is 25.2% (19.4%, 31.4%)\n\nInterpretationLarge groups of individuals have a relatively small epidemiological impact; small and medium sized groups between 10 and 50 people have a larger impact on an epidemic.","funder":"NA","published":"10.1098\/rstb.2020.0273","server":"medRxiv"},{"title":"Under detection of depression in primary care settings in low and middle-income countries: A systematic review and meta-analysis","authors":"Fekadu, A.; Demissie, M.; Birhane, R.; Medhin, G.; Bitew, T.; Hailemariam, M.; Minaye, A.; Habtamu, K.; Milkias, B.; Petersen, I.; Patel, V.; Cleare, A. J.; Mayston, R.; Thornicroft, G.; Alem, A.; Hanlon, C.; Prince, M.","author_corresponding":"Abebaw Fekadu","author_corresponding_institution":"Centre for Innovative Drug Development and Therapeutic Trials for Africa (CDT-Africa), Addis Ababa University, Addis Ababa, Ethiopia; Department of Psychiatry, ","doi":"10.1101\/2020.03.20.20039628","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039628.source.xml","abstract":"ObjectiveDepression is the commonest mental disorder in primary care but is poor identified. The objective of this review was to determine the level of detection of depression by primary care clinicians and its determinants in studies from low-and middle-income countries (LMICs).\n\nMethods\n\nDesignSystematic review and meta-analysis. Review protocol was registered in the PROSPERO database (CRD42016039704).\n\nDatabasesPubMed, PsycINFO, Medline, EMBASE, LILAC and AJOL.\n\nQuality assessmentRisk of bias within studies evaluated with the Effective Public Health Practice Project (EPHPP).\n\nSynthesis\"Gold standard\" diagnosis for the purposes of this review were based on the 9-item Patient Health Questionnaire (PHQ-9; cutoff scores of 5 and 10), structured interview or expert diagnosis. Meta-analysis was conducted excluding studies on special populations. Analysis of pooled data were stratified by diagnostic approaches.\n\nResultsA total of 2223 non-duplicate publications were screened. Ten publications, from two multi-country studies and eight single country studies, making 18 country level reports, were included. One of the multi-country studies used an enriched sample of screen positive participants. Overall methodological quality of the studies was good. Depression detection was 0.0% in five reports and <12% in another five. The pooled detection for two reports that used PHQ-9 at a cutoff point of 5 (combined sample size = 1426) was 3.9% (95% CI = 2.3%, 5.5%); in the four reports that used PHQ-9 cutoff score of 10 (combined sample size =5481), the pooled detection was 7.0% (95% CI = 3.9%, 10.2%). For the enriched sample, the pooled detection was 43.5 % (95% CI: 25.7%, 61.0%). Severity of depression and suicidality were significantly associated with detection.\n\nConclusionsThe extremely low detection of depression by primary care clinicians poses a serious threat to scaling up mental healthcare in LMICs. Interventions to improve detection should be prioritized.\n\nStrength and limitation of study{blacktriangleright} This is the first review of detection of depression in LMIC settings\n{blacktriangleright}The review was comprehensive in terms of databases searched\n{blacktriangleright}Screening tools were used as gold standards, which may lead to overestimation of prevalence and underestimation of detection\n{blacktriangleright}The small number of studies and the use of different instruments and cutoff\n{blacktriangleright}points precluded exploration of sources of heterogeneity\n{blacktriangleright}The review does not include studies on distress or sub-threshold depression","funder":"NA","published":"10.1186\/s13643-022-01893-9","server":"medRxiv"},{"title":"A Tempo-geographic Analysis of Global COVID-19 Epidemic Outside of China","authors":"Liao, H.; Marley, G.; Si, Y.; Wang, Z.; Xie, Y.; Wang, C.; Tang, W.","author_corresponding":"Weiming Tang","author_corresponding_institution":"Dermatology Hospital, Southern Medical University, and the University of North Carolina at Chapel Hill Project-China","doi":"10.1101\/2020.03.20.20039602","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"public and global health","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20039602.source.xml","abstract":"BackgroundUnderstanding the global epidemic trends, geographic distribution, and transmission patterns of COVID-19 contribute to providing timely information for the global response of the epidemic. This study aims to understand the global pandemic geospatial patterns and trends and identify new epicenters requiring urgent attention.\n\nMethodsData on COVID-19 between 31st Dec. 2019 and 14th Mar. 2020 was included. The epidemic trend was analyzed using joinpoint regressions; the growth of affected countries was by descriptive analysis; and the global distribution and transmission trend by spatial analysis. Findings: The number of new cases in the regions outside of China slowly increased before 24th Feb. and rapidly accelerated after 24th Feb. Compared to China, other affected countries experienced a longer duration of a slow increase at the early stage and rapid growth at the latter stages. The first apparent increase in the number of affected countries occurred from 23rd Jan to 1st Feb, and the second apparent increase started from 25th Feb. The fist COVID-19 cases reported by countries from 28th Feb. were mainly imported from Europe. The geographic distribution changed from single-center (13th Jan. - 20th Feb.) to multi-centers pattern (20th Feb. - 14th Mar.). More countries were affected with COVID-19 and developed local transmission.\n\nInterpretationThe joinpoint regression and geospatial analysis indicated a multi-center pandemic of COVID-19. Strategies to prevent the new multiple centers as well as prevent ongoing transmission are needed.\n\nFundingNIH.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Prostatic Peripheral Zone Thickness: What is Normal on Magnetic Resonance Imaging?","authors":"Wasserman, N. F.; Spilseth, B.; Sanghvi, T.","author_corresponding":"Neil F Wasserman","author_corresponding_institution":"University of Minnesota","doi":"10.1101\/2020.03.21.20039149","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"radiology and imaging","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20039149.source.xml","abstract":"PurposeTo report the precision of a technique of measuring the PZ thickness on T2-weighted MRI and report normal parameters in patients with normal-sized prostates. We also wanted to establish the mean and second standard deviations (2SD) above and below the mean as criteria for abnormally narrow or expanded PZ thickness.\n\nMethodsOf the initial 1566 consecutive cohort referred for evaluation for carcinoma based on elevated PSA (prostate specific antibody) or DRE (digital rectal examination), 132 separate subjects with normal-sized prostates were selected for this study. Mean age was 58.2 years (15-82). Median serum PSA was 6.2ng\/ML (range, 0.3-145). Most were asymptomatic for lower urinary tract symptoms (LUTS). Inclusion criteria in this study required technically adequate T2-weighted MRI and total prostatic volume (TPV) [&le;] 25 cc. Exclusion criteria included post prostatic surgical and radiation patients, patients having had medical management or minimally invasive therapy for BPH, those being treated for prostatitis. Patients with suspected tumor expanding or obscuring measurement boundaries were also not considered. Transition zone (TZ) and peripheral zone (PZ) volumes were determined using the prolate ellipsoid model. Postero-lateral measurement of the PZ was obtained at the axial level of maximal transverse diameter of the prostate on a line drawn from the outer boundary of the TZ to the inner boundary of the external prostatic capsule. The data was normally distributed. Therefore, it was analyzed using the 2-sided student t-test and Pearson produce correlation statistic.\n\nResultsMean pooled (composite) measurement for the postero-lateral PZ (PLPZ) was 10 mm (CI= 9.5-10.5 mm) with SD of 2.87 mm. Means were statistically the same for the 2 observers (p=0.75). Pearson correlation between the two observers was 0.63.\n\nConclusionsIn a prostate [&le;] 25 cc volume the postero-lateral PZ should be no thicker than 15.8 mm and averages 10.0 mm. when measured in the maximal axial plane on MRI. These norms were independent of age or use of endorectal coil. The technique measurement demonstrated clinically useful precision.","funder":"NA","published":"10.1007\/s00261-020-02650-z","server":"medRxiv"},{"title":"ACE-2 Expression in the Small Airway Epithelia of Smokers and COPD Patients: Implications for COVID-19","authors":"Leung, J. M.; Yang, C. X.; Tam, A.; Shaipanich, T.; Hackett, T. L.; Singhera, G. K.; Dorscheid, D. R.; Sin, D. D.","author_corresponding":"Don D Sin","author_corresponding_institution":"University of British Columbia (UBC) Centre for Heart Lung Innovation","doi":"10.1101\/2020.03.18.20038455","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"respiratory medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038455.source.xml","abstract":"IntroductionCoronavirus disease 2019 (COVID-19) is a respiratory infection caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). This virus uses the angiotensin converting enzyme II (ACE-2) as the cellular entry receptor to infect the lower respiratory tract. Because individuals with chronic obstructive pulmonary disease (COPD) are at increased risk of severe COVID-19, we determined whether ACE-2 expression in the lower airways was related to COPD and cigarette smoking.\n\nMethodsUsing RNA-seq, we determined gene expression levels in bronchial epithelia obtained from cytologic brushings of 6th to 8th generation airways in individuals with and without COPD. We eternally validated these results from two additional independent cohorts, which used microarray technologies to measure gene expression levels from 6th to 12th generation airways.\n\nResultsIn the discovery cohort (n=42 participants), we found that ACE-2 expression levels were increased by 48% in the airways of COPD compared with non-COPD subjects (COPD=2.52{+\/-}0.66 log2 counts per million reads (CPM) versus non-COPD= 1.70{+\/-}0.51 CPM, p=7.62x10-4). There was a significant inverse relationship between ACE-2 gene expression and FEV1% of predicted (r=-0.24; p=0.035). Current smoking also significantly increased ACE-2 expression levels compared with never smokers (never current smokers=2.77{+\/-}0.91 CPM versus smokers=1.78{+\/-}0.39 CPM, p=0.024). These findings were replicated in the two eternal cohorts.\n\nConclusionsACE-2 expression in lower airways is increased in patients with COPD and with current smoking. These data suggest that these two subgroups are at increased risk of serious COVID-19 infection and highlight the importance of smoking cessation in reducing the risk.","funder":"NA","published":"10.1183\/13993003.00688-2020","server":"medRxiv"},{"title":"State Laws and Regulations Addressing Nurse-Initiated Protocols and Use of Nurse-Initiated Protocols in Emergency Departments: A Mixed-methods Cross-sectional Survey Study","authors":"Castner, J.; Boris, L.","author_corresponding":"Jessica Castner","author_corresponding_institution":"Castner Incorporated","doi":"10.1101\/2020.03.19.20038414","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"nursing","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038414.source.xml","abstract":"IntroductionState regulations may impede the use of nurse-initiated protocols to begin life-saving treatments when patients arrive to the emergency department. In crowding and small-scale disaster events, this could translate to life and death practice differences. Nevertheless, research demonstrates nurses do utilize nurse-initiated protocols despite legal prohibitions. The purpose of this study was to explore the relationship of the state regulatory environment as expressed in nurse practice acts and interpretive statements prohibiting the use of nurse-initiated protocols with hospital use of nurse-initiated protocols in emergency departments.\n\nMethodsA mixed-methods approach was used with a cross-sectional nationwide survey. The independent variable categorized the location of the hospital in states that have a protocol prohibition. Outcomes included protocols for blood laboratory tests, x-rays, over the counter medication, and electrocardiograms. A second analysis was completed with New York State alone because this state has the strongest language prohibiting nurse-initiated protocols.\n\nResults350 surveys from 48 states and the District of Columbia were received. A hospital was more likely to have policies supporting nurse-initiated protocols if they were not in a state with scope of practice prohibitions. Four qualitative categories emerged: advantages, approval, prohibition, and conditions under which protocols can be used. Prohibitive language was associated with less protocol use for emergency care.\n\nConclusionState scope of practice inconsistencies create misalignment with emergency nurse education and training, which may impede timely care and contribute to inequalities and inefficiencies in emergency care. In addition, prohibitive language places practicing nurses responding to emergencies in crowded work environments at risk.","funder":"NA","published":"10.1177\/1527154420954457","server":"medRxiv"},{"title":"Early Outcomes of Preoperative 5-fraction Radiation Therapy for Soft Tissue Sarcoma Followed by Immediate Surgical Resection","authors":"Parsai, S.; Lawrenz, J.; Kilpatrick, S.; Rubin, B.; Hymes, C.; Gray, M.; Mesko, N.; Shah, C.; Nystrom, L.; Scott, J. G.","author_corresponding":"Jacob G Scott","author_corresponding_institution":"Department of Radiation Oncology, Taussig Cancer Institute, Cleveland Clinic, 10201 Carnegie Ave, Cleveland, OH 44195, USA","doi":"10.1101\/2020.03.20.20038885","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"oncology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20038885.source.xml","abstract":"Purpose\/ObjectivesThere are limited data regarding the use of hypofractionated radiation therapy (RT) for soft tissue sarcoma. We report early oncologic outcomes and wound complications of patients undergoing preoperative hypofractionated (5 fraction) RT followed by immediate surgical resection.\n\nMaterials\/MethodsAn IRB-approved database of patients treated with preoperative RT for soft tissue sarcoma was queried. Patients treated with a hypofractionated dosing regimen followed by immediate (within 7 days) planned wide surgical resection were identified.\n\nResultsBetween 2016 to 2019, sixteen patients met eligibility criteria. The median clinical follow-up was 10.7 months (range 1.7-33.2). The median patient age was 64 years old (range 33-88). Ten of the sarcomas were located in the lower extremity, 4 in the upper extremity, and two were located in the trunk. Five patients had metastatic disease at diagnosis. The majority of the patients received a total radiation dose of 30 Gy in 5 fractions (range 27.5-40 Gy) on consecutive days. All patients were planned with IMRT\/VMAT. The median time to surgical resection following the completion of RT was 1 day (range 0-7 days). The median time from initial biopsy results to completion of primary oncologic therapy was 20 days (range 16-35). Ten patients achieved R0 resection, whereas the remaining 6 patients achieved R1 resection. Of the 13 patients assessed for local control, no patients developed local failure. Five patients developed wound healing complications (31%), of which only three patients (19%) required return to the operating room.\n\nConclusionsTreatment of soft tissue sarcoma with preoperative hypofractionated RT followed by immediate resection resulted in a median of 20 days from biopsy results to completion of oncologic therapy. Early outcomes demonstrate favorable wound healing. Further prospective data with long-term follow-up is required to determine the oncologic outcomes and toxicity of hypofractionated preoperative RT.","funder":"NA","published":"10.1016\/j.adro.2020.06.024","server":"medRxiv"},{"title":"The contribution of X-linked coding variation to severe developmental disorders","authors":"Martin, H. C.; Gardner, E. J.; Samocha, K. E.; Kaplanis, J.; Akawi, N.; Sifrim, A.; Eberhardt, R. Y.; Taylor Tavares, A. L.; Neville, M. D.; Niemi, M. E. K.; Gallone, G.; McRae, J.; Wright, C. F.; FitzPatrick, D. R.; Firth, H. V.; Hurles, M. E.","author_corresponding":"Hilary C Martin","author_corresponding_institution":"Wellcome Sanger Institute","doi":"10.1101\/2020.03.18.20037960","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20037960.source.xml","abstract":"Over 130 X-linked genes have been robustly associated with developmental disorders (DDs), and X-linked causes have been hypothesised to underlie the higher DD rates in males. We evaluated the burden of X-linked coding variation in 11,046 DD patients, and found a similar rate of X-linked causes in males and females (6.0% and 6.9%, respectively), indicating that such variants do not account for the 1.4-fold male bias. We developed an improved strategy to detect novel X-linked DDs and identified 23 significant genes, all of which were previously known, consistent with our inference that the vast majority of the X-linked burden is in known DD-associated genes. Importantly, we estimated that, in male probands, only 13% of inherited rare missense variants in known DD-associated genes are likely to be pathogenic. Our results demonstrate that statistical analysis of large datasets can refine our understanding of modes of inheritance for individual X-linked disorders.","funder":"NA","published":"10.1038\/s41467-020-20852-3","server":"medRxiv"},{"title":"The general impact of haploinsufficiency on brain connectivity underlies the pleiotropic effect of neuropsychiatric CNVs","authors":"Moreau, C.; Huguet, G.; Urchs, S.; Douard, E. A.; Sharmarke, H.; Orban, P.; Labbe, A.; Modenato, C.; Martin-Brevet, S.; Kuldeep, K.; Martin, C.-O.; Jizi, K.; Younis, N.; Tamer, P.; Martineau, J.-L.; Silva, A. I.; Jonch, A. E.; Lin, A.; Simons VIP Foundation,  ; Hall, J.; van den Bree, M. B.; Owen, M. J.; Linden, D. E.; Maillard, A.; Lippe, S.; Greenwood, C. M.; Bearden, C. E.; Thompson, P. M.; Bellec, P.; Jacquemont, S.","author_corresponding":"Clara Moreau","author_corresponding_institution":"Research Center of the UHC of Sainte Justine, University of Montreal","doi":"10.1101\/2020.03.18.20038505","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"genetic and genomic medicine","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038505.source.xml","abstract":"Copy number variants (CNVs) are among the most highly penetrant genetic risk factors for neuropsychiatric disorders. Their impact on brain connectivity remains mostly unstudied. Because they confer risk for overlapping conditions, we hypothesized that they may converge on shared connectivity patterns.\n\nWe performed connectome-wide analyses using resting-state functional MRI data from 436 carriers of neuropsychiatric CNVs at the 1q21.1, 15q11.2, 16p11.2, 22q11.2 loci, 4 \"neutral effect\" CNVs, 66 carriers of scarcer neuropsychiatric CNVs, 756 individuals with idiopathic autism spectrum disorder (ASD), schizophrenia, attention deficit hyperactivity disorder, and 5,377 controls. Neuropsychiatric CNVs showed global shifts of mean connectivity. The effect size of CNVs on relative connectivity (adjusted for the mean) was correlated with the known level of neuropsychiatric risk conferred by CNVs. Individuals with idiopathic schizophrenia and ASD had similarities in connectivity with neuropsychiatric CNVs. We reported a linear relationship between connectivity and intolerance to haploinsufficiency measured for all genes encompassed by CNVs across 18 loci. This profile involved the thalamus, the basal ganglia, somatomotor and frontoparietal networks and was correlated with lower general intelligence and higher autism severity scores. An exploratory factor analysis confirmed the contribution of these regions to three latent components shared across CNVs and neuropsychiatric disorders.\n\nWe posit that deleting genes intolerant to haploinsufficiency reorganize connectivity along general dimensions irrespective of where deletions occur in the genome. This haploinsufficiency brain signature opens new avenues to understand polygenicity in psychiatric conditions and the pleiotropic effect of CNVs on cognition and risk for neuropsychiatric disorders.\n\nOne sentence summaryNeuropsychiatric CNVs across the genome reorganize brain connectivity architecture along dominant patterns contributing to complex idiopathic conditions.","funder":"NA","published":"10.1016\/j.biopsych.2021.02.115","server":"medRxiv"},{"title":"Supervised Machine Learning for the Early Prediction of Acute Respiratory Distress Syndrome (ARDS)","authors":"Le, S.; Pellegrini, E.; Green-Saxena, A.; Summers, C.; Hoffman, J.; Calvert, J.; Das, R.","author_corresponding":"Abigail Green-Saxena","author_corresponding_institution":"Dascena Inc., Oakland, CA, United States","doi":"10.1101\/2020.03.19.20038364","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038364.source.xml","abstract":"PurposeAcute respiratory distress syndrome (ARDS) is a serious respiratory condition with high mortality and associated morbidity. The objective of this study is to develop and evaluate a novel application of gradient boosted tree models trained on patient health record data for the early prediction of ARDS.\n\nMaterials and Methods9919 patient encounters were retrospectively analyzed from the Medical Information Mart for Intensive Care III (MIMIC-III) data base. XGBoost gradient boosted tree models for early ARDS prediction were created using routinely collected clinical variables and numerical representations of radiology reports as inputs. XGBoost models were iteratively trained and validated using 10-fold cross validation.\n\nResultsOn a hold-out test set, algorithm classifiers attained area under the receiver operating characteristic curve (AUROC) values of 0.905, 0.827, 0.810, and 0.790 when tested for the prediction of ARDS at 0-, 12-, 24-, and 48-hour windows prior to onset, respectively.\n\nConclusionSupervised machine learning predictions may help predict patients with ARDS up to 48 hours prior to onset.","funder":"NA","published":"10.1016\/j.jcrc.2020.07.019","server":"medRxiv"},{"title":"Bibliometric Analysis of Global Scientific Research on SARSCoV-2 (COVID-19)","authors":"Rafiei Nasab, F.; rahim, F.","author_corresponding":"Fakher rahim","author_corresponding_institution":"Ahvaz Jundishapur University of Medical Sciences","doi":"10.1101\/2020.03.19.20038752","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"health informatics","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038752.source.xml","abstract":"Background and AimSince late 2019, an unknown-origin pneumonia outbreak detected in Wuhan city, Hubei Province, China. We aimed to build a model to qualitatively and quantitatively assess publications of research of COVID-19 from 2019 to 2020.\n\nMaterials and MethodsData were obtained from the Web of Science (WOS), PubMed, and Scopus Core Collection on March 02, 2020, and updated on March 10. We conducted a qualitative and quantitative analysis of publication outputs, journals, authors, institutions, countries, cited references, keywords, and terms according to bibliometric methods using VOS viewer c software packages.\n\nResultsInitially, we identified 227 papers, of which after an exclusion process, 92 studies were selected for statistical analyses. China accounted for the highest proportion of published research (44 papers, 40.48%), followed by the United States (21 papers, 19.32%), and Canada (7 papers, 6.44%). Adjusted by gross domestic product (GDP), ranked first, with 0.003 articles per billion GDP. In total, the top 10 journals published 47 articles, which accounted for 51.08% of all publications in this Feld. A total of 6 studies (05.52%) were supported by National Natural Science Foundation of China. Chinese Academy of Sciences ranked second 2, 2.76%).\n\nConclusionBibliometric and visualized mapping may quantitatively monitor research performance in science and present predictions. The subject of this study was the fast growing publication on COVID-19. Most studies are published in journals with very high impact factors (IFs) and other journals are more interested in this type of research.\n\nHighlightsO_LIBibliometric description and mapping provided a birds-eye view of information on Covid-19 related research\nC_LIO_LIReaders to comprehend the history of published Covid-19 articles in just a few minutes.\nC_LIO_LIWe evaluated the research strength of countries and institutions,\nC_LIO_LIScholars might refer to in order to find cooperative institutions.\nC_LIO_LIDuring our research using the selected database, we tried to guarantee comprehension and objectivity.\nC_LI","funder":"NA","published":"10.22074\/cellj.2021.7794","server":"medRxiv"},{"title":"CAR T cell therapy in B-cell acute lymphoblastic leukaemia: Insights from mathematical models","authors":"Leon-Triana, O.; Sabir, S.; Calvo, G. F.; Belmonte-Beitia, J.; Chulian, S.; Martinez-Rubio, A.; Rosa, M.; Perez-Martinez, A.; Ramirez-Orellana, M.; Perez-Garcia, V.","author_corresponding":"Odelaisy Le\u00f3n-Triana","author_corresponding_institution":"University of Castilla-La Mancha","doi":"10.1101\/2020.03.18.20038257","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"hematology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038257.source.xml","abstract":"Immunotherapies use components of the patient immune system to selectively target cancer cells. The use of CAR T cells to treat B-cell malignancies - leukaemias and lymphomas- is one of the most successful examples, with many patients experiencing long-lasting complete responses to this therapy. This treatment works by extracting the patients T cells and adding them the CAR group, which enables them to recognize and target cells carrying the antigen CD19+, that is expressed in these haematological tumors.\n\nHere we put forward a mathematical model describing the time response of leukaemias to the injection of CAR T-cells. The model accounts for mature and progenitor B-cells, tumor cells, CAR T cells and side effects by incorporating the main biological processes involved. The model explains the early post-injection dynamics of the different compartments and the fact that the number of CAR T cells injected does not critically affect the treatment outcome. An explicit formula is found that provides the maximum CAR T cell expansion in-vivo and the severity of side effects. Our mathematical model captures other known features of the response to this immunotherapy. It also predicts that CD19+ tumor relapses could be the result of the competition between tumor and CAR T cells analogous to predator-prey dynamics. We discuss this fact on the light of available evidences and the possibility of controlling relapses by early re-challenging of the tumor with stored CAR T cells.","funder":"NA","published":"10.1016\/j.cnsns.2020.105570","server":"medRxiv"},{"title":"Clinical characteristics and reasons of different duration from onset to release from quarantine for patients with COVID-19 Outside Hubei province, China.","authors":"Tian, S.; Chang, Z.; Wang, Y.; Wu, M.; Zhang, W.; Zhou, G.; Zou, X.; Tian, H.; Xiao, T.; Xing, J.; Chen, J.; Han, J.; Ning, K.; Wu, T.","author_corresponding":"Suochen Tian","author_corresponding_institution":"1.\tDepartment of Intensive Care Unit, Liaocheng people\\'s hospital, Liaocheng, Shandong, 252000, China","doi":"10.1101\/2020.03.21.20038778","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20038778.source.xml","abstract":"ObjectiveTo find out more characteristics and rules of COVID-19 by analyzing the clinical course of COVID-19 patients in a region outside Hubei province.\n\nMethods37 cases diagnosed adult COVID-19 cases of general characteristics, history of epidemiology, chronic underlying diseases, clinical symptoms and complications, chest CT, biochemical monitoring, severity assessment, treatment and outcome were retrospectively analyzed, and according to the duration from onset to release from quarantine were divided into [&le;]20 -day group and > 20 -day group, compare the similarities and differences between the two groups.\n\nResultsAmong the 37 patients, 5 were mild, 30 were moderate, 1 was severe and 1 was critical. All the patients were released from quarantine without death. The average duration from onset to release from quarantine was 20.2{+\/-}6.6 days, The average length of stay from onset to hospitalization was 4.1{+\/-}3.7 days, and hospitalization duration average 16.1 {+\/-}6.2 days. The average age was 44.3{+\/-}1.67 years. 78.4% of cases were caused by exposure to a confirmed patient or the workplace of a confirmed patient. The main symptoms were cough (67.6%), fever (62.2%), shortness of breath (32.4%), fatigue (24.3%), sore throat (21.6%,) vomiting or diarrhea (21.6%). The white blood cell count was decreased in 27.0% of the patients, and the lymphocyte count was decreased in 62.2% of the patients, of which 43.5% patients were [&le;]0.6x109\/L. On admission, 86.5% of patients with chest CT showed pneumonia, including some asymptomatic patients. 68.8% of patients showed bilateral infiltration. In the > 20-day group, the average age was 49.9{+\/-}1.38 years old, and the duration from onset to hospitalization was 5.5{+\/-}3.9 days. Compared with the [&le;] 20-day group, the age was older and duration was longer, P < 0.05. All the 7 asymptomatic patients were [&le;]20 -day group. When 37 patients were released from quarantine, the white blood cell count of 16.2% patients was < 4.0x109\/L, and the lymphocyte count of 59.5% patients was <1.1x109\/L, and the absolute count of white blood cells and lymphocytes was 5.02{+\/-}1.3 4x109\/L and 1.03{+\/-}0.34x109\/L respectively, compared with those on admission, P > 0.05.\n\nConclusionThe majority of COVID-19 cases in the study area were mild and moderate, with good clinical outcomes. There were some special characteristics in the clinical process. The reasons of duration from onset to release from quarantine were complex. There was no significant change in the number of granulocytes at the time of release from quarantine compared to the time of admission.","funder":"NA","published":"10.3389\/fmed.2020.00210","server":"medRxiv"},{"title":"From a single host to global spread. The global mobility based modelling of the COVID-19 pandemic implies higher infection and lower detection rates than current estimates.","authors":"Siwiak, M. M.; Szczesny, P.; Siwiak, M. P.","author_corresponding":"Marian P Siwiak","author_corresponding_institution":"Data 3.0","doi":"10.1101\/2020.03.21.20040444","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.21.20040444.source.xml","abstract":"BackgroundSince the outbreak of the COVID-19 pandemic, multiple efforts of modelling of the geo-temporal transmissibility of the virus have been undertaken, but none describes the pandemic spread at the global level. The aim of this research is to provide a high-resolution global model of the pandemic that overcomes the problem of biased country-level data on the number of infected cases. To achieve this we propose a novel SIR-type metapopulation transmission model and a set of analytically derived model parameters. We used them to perform a simulation of the disease spread with help of the Global Epidemic and Mobility (GLEAM) framework embedding actual population densities, commute patterns and long-range travel networks. The simulation starts on Nov 17th, 2019 with just a single pre-symptomatic, yet infectious, case in Wuhan, China, and results in an accurate prediction of the number of diagnosed cases after 154 days in multiple countries across five continents. In addition, the model outcome shows high compliance with the results of a random screening test conducted on pregnant women in the New York area.\n\nMethodsWe have built a modified SIR metapopulation transmission model and parameterized it analytically either by setting the values of the parameters based on the literature, or by assuming their plausible values. We compared our results with the number of diagnosed cases in twenty selected countries which provide reliable statistics but differ substantially in terms of strength and speed of undertaken Non-Drug Interventions. The obtained 95% confidence intervals for the predictions are in agreement with the empirical data.\n\nResultsThe parameters that successfully model the pandemic are: the basic reproduction number R0, 4.4; a latent non-infectious period of 1.1. days followed by 4.6 days of the presymptomatic infectious period; the probability of developing severe symptoms, 0.01; the probability of being diagnosed when presenting severe symptoms of 0.6; the probability of diagnosis for cases with mild symptoms or asymptomatic, 0.001.\n\nDiscussionParameters that successfully reproduce the observed number of cases indicate that both R0 and the prevalence of the virus might be underestimated. This is in concordance with the newest research on undocumented COVID-19 cases. Consequently, the actual mortality rate is putatively lower than estimated. Confirmation of the pandemic characteristic by further refinement of the model and screening tests is crucial for developing an effective strategy for the global epidemiological crisis.","funder":"NA","published":"10.7717\/peerj.9548","server":"medRxiv"},{"title":"Estimating the reproduction number of COVID-19 in Iran using epidemic modeling","authors":"Sahafizadeh, E.; Sartoli, S.","author_corresponding":"Ebrahim Sahafizadeh","author_corresponding_institution":"Payame Noor University","doi":"10.1101\/2020.03.20.20038422","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20038422.source.xml","abstract":"BackgroundAs reported by Iranian governments, the first cases of coronavirus (COVID-19) infections confirmed in Qom, Iran on February 19, 2020 (30 Bahman 1398). The number of identified cases afterward increased rapidly and the novel coronavirus spread to all provinces of the country. This study aimed to fit an epidemic model to the reported cases data to estimate the basic reproduction number (R0) of COVID-19 in Iran.\n\nMethodsWe used data from February 21, 2020, to April 21, 2020, on the number of cases reported by Iranian governments and we employed the SIR (Susceptible-Infectious-Removed) epidemic spreading model to fit the transmission model to the reported cases data by tuning the parameters in order to estimate the basic reproduction number of COVID-19 in Iran.\n\nResultsThe value of reproduction number was estimated 4.86 in the first week and 4.5 in the second week. it decreased from 4.29 to 2.37 in the next four weeks. At the seventh week of the outbreak the reproduction number was reduced below one.\n\nConclusionsThe results indicate that the basic reproduction number of COVID-19 was significantly larger than one in the early stages of the outbreak. However, implementing social distancing and preventing travelling on Nowruz (Persian New Year) effectively reduced the reproduction number. Although the results indicate that reproduction number is below one, it is necessary to continue social distancing and control travelling to prevent causing a second wave of outbreak.","funder":"NA","published":"10.1093\/jtm\/taaa077","server":"medRxiv"},{"title":"Association between Clinical, Laboratory and CT Characteristics and RT-PCR Results in the Follow-up of COVID-19 patients","authors":"Fu, H.; Xu, H.; Zhang, N.; Xu, H.; Li, Z.; Chen, H.; Xu, R.; Sun, R.; Wen, L.; Xie, L.; Liu, H.; Zhang, K.; Fu, C.; Hou, K.; Yang, Z.; Yang, M.; Guo, Y.","author_corresponding":"Yingkun Guo Sr.","author_corresponding_institution":"Department of Radiology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of Ministry of Education, West China Second University Hospi","doi":"10.1101\/2020.03.19.20038315","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038315.source.xml","abstract":"BackgroundSince December 2019, more than 100,000 coronavirus disease 2019 (COVID-19) patients have been confirmed globally based on positive viral nucleic acids with real-time reverse transcriptase-polymerase chain reaction (RT-PCR). However, the association between clinical, laboratory and CT characteristics and RT-PCR results is still unclear. We sought to examine this association in detail, especially in recovered patients.\n\nMethodsWe analysed data from 52 confirmed patients who had been discharged with COVID-19. The clinical, laboratory, and radiological data were dynamically recorded and compared with the admission and follow-up RT-PCR results.\n\nResultsIn this cohort, 52 admitted COVID-19 patients who had confirmed positive RT-PCR results were discharged after 2 rounds of consecutively negative RT-PCR results. Compared with admission levels, CRP levels (median 4.93 mg\/L [IQR: 1.78-10.20]) decreased significantly (p<0.001). and lymphocyte counts (median 1.50x109\/L [IQR: 1.11-1.88]) increased obviously after obtaining negative RT-PCR results (p<0.001). Additionally, substantially improved inflammatory exudation was observed on chest CT except for 2 progressed patients. At the two-week follow-up after discharge, 7 patients had re-positive RT-PCR results, including the abovementioned 2 progressed patients. Among the 7 patients, new GGO was demonstrated in 2 patients. There were no significant differences in CPR levels or lymphocyte counts when comparing the negative and re-positive PCT results (all p >0.05).\n\nConclusionHeterogeneity between CT features and RT-PCR results was found in COVID-19, especially in some recovered patients with negative RT-PCR results. Our study highlights that both RT-PCR and chest CT should be considered as the key determinants for the diagnosis and management of COVID-19 patients.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Clinical Characteristics of Coronavirus Disease 2019 in Hainan, China","authors":"Yan, S.; Song, X.; Lin, F.; Zhu, H.; Wang, X.; Li, M.; Ruan, J.; Lin, C.; Liu, X.; Wu, Q.; Luo, Z.; Fu, W.; Chen, S.; Yuan, Y.; Liu, S.; Yao, J.; Lv, C.","author_corresponding":"Chuanzhu Lv","author_corresponding_institution":"The Second Affiliated Hospital of Hainan Medical University","doi":"10.1101\/2020.03.19.20038539","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038539.source.xml","abstract":"BackgroundSince January 2020, coronavirus disease 2019 (Covid-19) has spread rapidly and developing the pandemic model around the world. Data have been needed on the clinical characteristics of the affected patients in an imported cases as model in island outside Wuhan.\n\nMethodsWe conducted a retrospective study included all 168 confirmed cases of Covid-19 in Hainan province from 22 January 2020 to 13 March 2020. Cases were confirmed by real-time RT-PCR and were analysed for demographic, clinical, radiological and laboratory data.\n\nResultsOf 168 patients, 160 have been discharged, 6 have died and 2 remain hospitalized. The median age was 51.0 years and 51.8% were females. 129 (76.8%) patients were imported cases, and 118 (70.2%), 51 (30.4%) and 52 (31%) of patients lived in Wuhan or traveled to Wuhan, had contact with Covid-19 patients, or had contact with Wuhan residents, respectively. The most common symptoms at onset of illness were fever (65.5%), dry cough (48.8%) and expectoration (32.1%). On admission, ground-glass opacity was the most common radiologic finding on chest computed tomography (60.2%). The elderly people with diabetes, hypertension and CVD are more likely to develop severe cases. Follow-up of 160 discharged patients found that 20 patients (12.5%) had a positive RT-PCR test results of pharyngeal swabs or anal swabs or fecal.\n\nConclusionsIn light of the rapid spread of Covid-19 around the world, early diagnosis and quarantine is important to curb the spread of Covid-19 and intensive treatments in early stage is to prevent patients away from critical condition.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Effectiveness and safety of antiviral or antibody treatments for coronavirus","authors":"Rios, P.; Radhakrishnan, A.; Antony, J.; Thomas, S. M.; Muller, M.; Straus, S. E.; Tricco, A. C.","author_corresponding":"Andrea C. Tricco","author_corresponding_institution":"Li Ka Shing Research Institute, Knowledge Translation Program, St. Michael\\'s Hospital","doi":"10.1101\/2020.03.19.20039008","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"infectious diseases","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20039008.source.xml","abstract":"BackgroundTo identify safe and effective medical countermeasures (e.g., antivirals\/antibodies) to address the current outbreak of a novel coronavirus (COVID-19)\n\nMethodsComprehensive literature searches were developed by an experienced librarian for MEDLINE, EMBASE, the Cochrane Library, and biorxiv.org\/medrxiv.org; additional searches for ongoing trials and unpublished studies were conducted in clinicaltrials.gov and the Global Infectious Diseases and Epidemiology Network (GIDEON). Title\/abstract and full-text screening, data abstraction, and risk of bias appraisal were carried out by single reviewers.\n\nResults54 studies were included in the review: three controlled trials, 10 cohort studies, seven retrospective medical record\/database studies, and 34 case reports or series. These studies included patients with severe acute respiratory syndrome (SARs, n=33), middle east respiratory syndrome (MERS, n=16), COVID-19 (n=3), and unspecified coronavirus (n=2). The most common treatment was ribavirin (n=41), followed by oseltamivir (n=10) and the combination of lopinavir\/ritonavir (n=7). Additional therapies included broad spectrum antibiotics (n=30), steroids (n=39) or various interferons (n=12). No eligible studies examining monoclonal antibodies for COVID-19 were identified. One trial found that ribavirin prophylactic treatment statistically significantly reduced risk of MERS infection in people who had been exposed to the virus. Of the 21 studies reporting rates of ICU admission in hospitalized SARS or MERS patients, none reported statistically significant results in favour of or against antiviral therapies. Of the 40 studies reporting mortality rates in hospitalized SARS or MERS patients, one cohort study (MERS) and one retrospective study (SARS) found a statistically significant increase in the mortality rate for patients treated with ribavirin. Eighteen studies reported potential drug-related adverse effects including gastrointestinal symptoms, anemia, and altered liver function in patients receiving ribavirin.\n\nConclusionThe current evidence for the effectiveness and safety of antiviral therapies for coronavirus is inconclusive and suffers from a lack of well-designed prospective trials or observational studies, preventing any treatment recommendations from being made. However, it is clear that the existing body of evidence is weighted heavily towards ribavirin (41\/54 studies), which has not shown conclusive evidence of effectiveness and may cause harmful adverse events so future investigations may consider focusing on other candidates for antiviral therapy.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Now-casting the COVID-19 epidemic: The use case of Japan, March 2020","authors":"Gloeckner, S.; Krause, G.; Hoehle, M.","author_corresponding":"Stephan Gloeckner","author_corresponding_institution":"Department of Epidemiology, Helmholtz Center for Infection Research","doi":"10.1101\/2020.03.18.20037473","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20037473.source.xml","abstract":"BackgroundReporting delays in disease surveillance impair the ability to assess the current dynamic of an epidemic. In continuously updated epidemic curves, case numbers for the most recent epidemic week or day usually appear to be lower than the previous, suggesting a decline of the epidemic. In reality, the epidemic curve may still be on the rise, because reporting delay prevents the most recent cases to appear in the case count. In context of the COVID-19 epidemic and for countries planning large international gatherings, such as the Summer Olympic Games in Japan 2020, the ability to assess the actual stage of an epidemic is of outmost importance.\n\nMethodsWe applied now-casting onto COVID-19 data provided by the nCoV-2019 Data Working Group to evaluate the true count of cases, by taking into account reporting delays occurring between date of symptom onset and date of confirmation.\n\nFindingsWe calculated a decrease of reporting delay, from a median delay of ten days in calendar week four 2020 to six days in calendar week eight, resulting in an overall mean of 4.3 days. The confidence intervals of the now-casting indicated an increase of cases in the last reporting days, while case country in that same time period suggested a decline.\n\nInterpretationAs a specific use case this tool may be of particular value for the challenging risk assessment and risk communication in the context of the Summer Olympic Games in Japan 2020 and similar situations elsewhere.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"A model for COVID-19 prediction in Iran based on China parameters","authors":"Zareie, B.; Roshani, A.; Mansournia, M. A.; Rasouli, M. A.; Moradi, G.","author_corresponding":"Ghobad Moradi","author_corresponding_institution":"Kurdistan University of Medical Sciences","doi":"10.1101\/2020.03.19.20038950","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038950.source.xml","abstract":"BackgroundThe rapid spread of COVID-19 virus from China to other countries and outbreaks of disease require an epidemiological analysis of the disease in the shortest time and an increased awareness of effective interventions. The purpose of this study was to estimate the COVID-19 epidemic in Iran based on the SIR model. The results of the analysis of the epidemiological data of Iran from January 22 to March 8, 2020 were investigated and the prediction was made until March 29, 2020.\n\nMethodsBy estimating the three parameters of time-dependent transmission rate, time-dependent recovery rate, and time-dependent mortality rate from Covid-19 outbreak in China, and using the number of Covid-19 infections in Iran, we predicted the number of patients for the next month in Iran. Each of these parameters was estimated using GAM models. All analyses were conducted in R software using the mgcv package.\n\nFindingsOn average, 925 people with COVID-19 are expected to be infected daily in Iran. The epidemic peaks within one week (15.03.2020 to 03.21.2020) and reaches its highest point on 03.18.2020 with 1126 infected cases.\n\nConclusionThe most important point is to emphasize the timing of the epidemic peak, hospital readiness, government measures and public readiness to reduce social contact.","funder":"NA","published":"10.34172\/aim.2020.05","server":"medRxiv"},{"title":"Covid-19 dynamics in Albania: first estimates and projections","authors":"Gjini, E.","author_corresponding":"Erida Gjini","author_corresponding_institution":"Instituto Gulbenkian de Ciencia","doi":"10.1101\/2020.03.20.20038141","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.20.20038141.source.xml","abstract":"The SARS-CoV-2 epidemic is one of the biggest challenges healthcare systems worldwide have ever had to face. To curb transmission many countries have adopted social distancing measures and travel restrictions. Estimating the effect of these measures in each context is challenging and requires mathematical models of the transmission dynamics. Projections for the future course of the epidemic strongly rely on model predictions and accurate representation of real-time data as they accumulate. Here I develop an SEIR modeling framework for Covid-19, to evaluate reported cases and fatalities, and to enable forecasting using evidence-based Bayesian parameter estimation. This Bayesian framework offers a tool to parametrize real-time dynamics of Covid-19 cases, and explore the effect of control as it unfolds in any setting. I apply the model to Covid-19 data from Albania, where drastic control measures were put in place already on the day of the first confirmed case. Evaluating the dynamics of reported cases 9-31 March 2020, I estimate parameters and make preliminary projections. Three weeks into the measures, Albanian data already indicate a strong signature of more than 40% transmission reduction, and lend support to a progressively increasing effect of control measures rather than a static one. In the Albanian setting, the model and data match well, projecting the peak of the outbreak may be around 5-15 April, and be contained within 300 active confirmed cases if control continues with the same trend. This framework can be used to understand the quantitative effects of different control measures in real-time, and inform adaptive intervention for success in other settings.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Climatic influences on the worldwide spread of SARS-CoV-2","authors":"Bariotakis, M.; Sourvinos, G.; Castanas, E.; Pirintsos, S. A.","author_corresponding":"Stergios A Pirintsos","author_corresponding_institution":"Department of Biology, University of Crete","doi":"10.1101\/2020.03.19.20038158","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_by_nc_nd","category":"epidemiology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.19.20038158.source.xml","abstract":"The rapid global spread of the novel, pathogenic, SARS-CoV-2 causing the severe acute respiratory disease COVID-19, becomes a major health problem worldwide and pose the need for international predictive programs. Given the lack of both specific drugs and an efficient preventive vaccine, the expectation that SARS-CoV-2s transmission rate might decrease in temperate regions during summer, dominated the social scene. Here, we attempted a prediction of the worldwide spread of the infections based on climatic data, expressed by 19 bioclimatic variables. The calculated probability maps shown that potential areas of infection follow a shift from the Tropical to Temperate and Mediterranean Bioclimatic regions, and back to the Tropics again. Maps show an increased probability of infections in Europe, followed by an expansion covering areas of the Middle East and Northern Africa, as well as Eastern coastal areas of North America, South-Eastern coastal areas of Latin America and two areas of Southern Australia, and later return to areas of Southeastern Asia, in a manner similar to that of influenza strains (H3N2). Our approach may therefore be of value for the worldwide spread of SARS-CoV-2, suggesting an optimistic scenario of asynchronous seasonal global outbreaks, like other viral respiratory diseases. Consequently, we suggest the incorporation of a climatic impact in the design and implementation of public health policies. Maps of our model are available (constantly updated up to the saturation of the model) at: https:\/\/navaak.shinyapps.io\/CVRisk\/.","funder":"NA","published":"NA","server":"medRxiv"},{"title":"Differentiating the Effect of Medication and Illness on Brain Volume Reductions in First-Episode Psychosis: A Longitudinal, Randomized, Triple-blind, Placebo-controlled MRI study","authors":"Chopra, S.; Fornito, A.; Francey, S.; O'Donoghue, B.; Cropley, V.; Nelson, B.; Graham, J.; Baldwin, L.; Tahtalian, S.; Yuen, H. P.; Allott, K.; Alvarez-Jimenez, M.; Harrigan, S.; Sabaroedin, K.; Pantelis, C.; Wood, S. J.; McGorry, P.","author_corresponding":"Alex Fornito","author_corresponding_institution":"Monash University, Turner Institute for Brain and Mental Health, School of Psychological Sciences and Monash Biomedical Imaging","doi":"10.1101\/2020.03.18.20038471","date":"2020-03-23","version":"1","type":"PUBLISHAHEADOFPRINT","license":"cc_no","category":"psychiatry and clinical psychology","jatsxml":"https:\/\/www.medrxiv.org\/content\/early\/2020\/03\/23\/2020.03.18.20038471.source.xml","abstract":"Changes in brain volume are a common finding in Magnetic Resonance Imaging (MRI) studies of people with psychosis and numerous longitudinal studies suggest that volume deficits progress with illness duration. However, a major unresolved question concerns whether these changes are driven by the underlying illness or represent iatrogenic effects of antipsychotic medication. Here, we report MRI findings from a triple-blind randomised placebo-controlled study where 62 antipsychotic-naive patients with first episode psychosis (FEP) received either an atypical antipsychotic or a placebo pill over a treatment period of 6 months. Both FEP groups received intensive psychosocial therapy. A healthy control group (n=27) was also recruited. Structural MRI scans were obtained at baseline, 3-months and 12- months. Our primary aim was to differentiate illness-related brain volume changes from medication-related changes within the first 3 months of treatment. We secondarily investigated long-term effects at the 12-month timepoint. From baseline to 3 months, we observed a significant group x time interaction in the pallidum (p < 0.05 FWE-corrected), such that patients receiving antipsychotic medication showed increased volume, patients on placebo showed decreased volume, and healthy controls showed no change. In patients, a greater increase in pallidal grey matter volume over 3 months was associated with a greater reduction in symptom severity. We additionally found preliminary evidence for illness- related volume reductions in prefrontal cortices at 12 months and medication-related volume reductions in cerebellum at both 3-months and 12-months. Our findings indicate that psychotic illness and antipsychotic exposure exert distinct and spatially distributed effects on brain volume. Our results align with prior work in suggesting that the therapeutic efficacy of antipsychotic medications may be primarily mediated through their effects on the basal ganglia.","funder":"NA","published":"10.1038\/s41386-021-00980-0","server":"medRxiv"}]}